SRTAW vs ZBH · rev $248.7M vs P/E 23, rev $8.23B
Strata Critical Medical, Inc. (SRTAW) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
Latest reported ZBH revenue for 2025-12-31 was $8.23B. Net income was $705.1M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
SRTAW currently screens at market cap $0. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the SRTAW and ZBH stock pages for the full models.
Not investment advice.